Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jul 31, 2026
- Accession no.
- 0001106578-26-000110
- Filed
- Jul 31, 2026, 4:18 PM ET
- Trade date
- Jul 30, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.99M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $135.42 | +$1,286,490 | 333,943 | Indirect | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −644 | $523.04F3 | −$336,836.54 | 333,299 | Indirect | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −1,486 | $523.87F4 | −$778,478.1 | 331,813 | Indirect | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −4,846 | $524.88F5 | −$2,543,588.83 | 326,967 | Indirect | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −2,084 | $525.80F6 | −$1,095,763.03 | 324,883 | Indirect | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −400 | $526.92F7 | −$210,769.2 | 324,483 | Indirect | |
| Jul 30, 2026 | Common Stock | SSaleDisposed | −40 | $528.96 | −$21,158.4 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 236,910 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $522.43 to $523.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $523.43 to $524.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $524.43 to $525.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $525.43 to $526.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $526.50 to $527.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.